Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.485 USD | +0.34% | -10.30% | -43.94% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.94% | 71.99M | |
+18.69% | 125B | |
+13.88% | 108B | |
-7.49% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.94% | 16.37B | |
+1.85% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Cue Biopharma Says Phase 1b Trial of CUE-101 With Pembrolizumab Shows 40% Overall Response Rate